Patents by Inventor Jean Richard

Jean Richard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240095645
    Abstract: A method of generating customizable goal representation is disclosed. A request from a user to view a goal representation is received. A flexible goal ontology is accessed that comprises one or more goal entities, one or more goal relationships between the goal entities, or one or more goal properties, the one or more goal properties including one or more metadata attributes relating to the one or more goal entities. A set of mapping rules is obtained that defines mappings between one or more goals. The set of mapping rules is evaluated to assemble a customized goal representation tailored to the user. The customized goal representation is updated based on a revaluation of the mapping rules affected by changes to the one or more goal entities, the one or more goal relationships, or the one or more properties.
    Type: Application
    Filed: September 21, 2023
    Publication date: March 21, 2024
    Inventors: Sven Martin Andreas Elfgren, Friedrich I. Riha, Elliot Piersa Dahl, Eric Koslow, Nicole Jensen McMullin, Natasha Hede, Connie Lynn Chen, Alexa Jean Kriebel, Chije Wang'ati, JR., Megan McGowan, Ami Tushar Bhatt, Jeffrey Ryan Gurr, Tyler Kowalewski, Rahul Rangnekar, Byron Sha Yang, Jerry Wu, Ricky Rizal Zein, Romain Beauxis, Adnan Chowdhury, Priya Balasubramanian, Gilles Yvetot, Shaylan Hawthorne, Adnan Pirzada, Matthew Michael Parides, Jenna Nicole Soojin Lee, Ian William Richard, Laura Elizabeth Pearson, Christian Nguyen, Tovin Thomas, Adam Carter, David Achee, David Christopher Sally, Miranda Howitt, Vincent Yao, Seth Goldenberg, Aimee Jin Peng, William Qingdong Yan, Matthew Stephen Wysocki, Michael Ryan Shohoney, Ryan Maas, Asha Camper Singh, Leonardo Faria, Elliot Piersa Dahl
  • Publication number: 20220372293
    Abstract: There are provided self-healing elastomeric materials and compositions and skin-like materials for use in a wide range of applications, particularly medical training simulators and mannequins. The self-healing elastomeric material comprises polysiloxane or poly ether soft segments connected via carbonate, urethane and/or urea bonds. The self-healing elastomeric material is intrinsically and/or thermally self- healing. Reusable devices, apparatuses and articles comprising the elastomeric materials as skin-like materials are disclosed.
    Type: Application
    Filed: October 21, 2020
    Publication date: November 24, 2022
    Inventors: Sumitra RAJAGOPALAN, Maksym KRYUCHKOV, Nicholas COTTENYE, Jean-Richard BULLET
  • Publication number: 20220243305
    Abstract: A nickel-based superalloy powder comprising, by mass percent, 14.00 to 15.25% chromium, 14.25 to 15.75% cobalt, 3.9 to 4.5% molybdenum, 4.0 to 4.6% aluminum, 3.0 to 3.7% titanium, 0 to 200 ppm carbon, the remainder consisting of nickel and unavoidable impurities. Component made from the powder and manufacturing process of the component.
    Type: Application
    Filed: June 18, 2020
    Publication date: August 4, 2022
    Applicant: SAFRAN
    Inventors: Sébastien Jean RICHARD, Jérémy RAME
  • Publication number: 20220056038
    Abstract: The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity.
    Type: Application
    Filed: May 4, 2021
    Publication date: February 24, 2022
    Inventors: Vincent P. Sandanayaka, Sharon Shacham, Michael Kauffman, Sharon Shechter, Dilara McCauley, Yosef Landesman, William Senapedis, Jean-Richard Saint-Martin
  • Publication number: 20210292873
    Abstract: The invention relates to a nickel-based superalloy including, in mass percentages: 5 to 6.5% aluminum, 4.5 to 7% cobalt, 14.5 to 16.5% chromium, 0 to 0.2% hafnium, 0 to 1.5% molybdenum, 2 to 3.5% tantalum, 0 to 2% titanium, 1 to 2.5% tungsten, 0 to 0.08% zirconium, 0 to 0.03% boron, 0 to 0.07% carbon, the remainder formed of nickel and unavoidable impurities.
    Type: Application
    Filed: July 24, 2019
    Publication date: September 23, 2021
    Applicant: SAFRAN
    Inventors: Sébastien Jean RICHARD, Jérémy RAME, Edern MENOU
  • Patent number: 10716321
    Abstract: Oligosaccharide mixtures consisting of at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide are provided. Food products, especially infant formula, comprising the oligosaccharide mixture are also provided.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: July 21, 2020
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Norbert Sprenger, Jean-Richard Neeser
  • Publication number: 20200180083
    Abstract: A method for welding together at least two parts of green material, referred to as green parts, by means of co-sintering, comprising the following steps:—assembling the at least two green parts at a junction zone of said parts so as to form a green one-piece assembly,—de-binding the green one-piece assembly, and—sintering the one-piece assembly so as to obtain a dense one-piece assembly forming a final part, characterised in that the two green parts (10, 12) each have a composition of different powder, so as to produce a final part (1) having at least two parts with different grain sizes.
    Type: Application
    Filed: June 1, 2018
    Publication date: June 11, 2020
    Inventor: Sebastien Jean RICHARD
  • Publication number: 20200087313
    Abstract: The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity.
    Type: Application
    Filed: April 25, 2019
    Publication date: March 19, 2020
    Inventors: Vincent P. Sandanayaka, Sharon Shacham, Michael Kauffman, Sharon Shechter, Dilara McCauley, Yosef Landesman, William Senapedis, Jean-Richard Saint-Martin
  • Patent number: 10587684
    Abstract: The disclosure describes components, apparatus and methods for providing network security between computing devices and/or networks on mobile platforms such as aircraft. One such apparatus may comprise: a first memory configured for data communication with a first computing device of the mobile platform; a second memory configured for data communication with a second computing device of the mobile platform; and a controller. The controller may be configured to detect a change in data stored In the first memory and cause the change in data stored in the first memory to be reflected in the second memory by causing data transfer from the first memory to the second memory. Data transfer between the first memory and the second memory may be conducted using a non-internet protocol.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: March 10, 2020
    Assignee: C SERIES AIRCRAFT LIMITED PARTNERSHIP
    Inventors: Jean-Richard Cote, Jayson Agagnier
  • Publication number: 20180110253
    Abstract: Oligosaccharide mixtures consisting of at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide are provided. Food products, especially infant formula, comprising the oligosaccharide mixture are also provided.
    Type: Application
    Filed: December 12, 2017
    Publication date: April 26, 2018
    Inventors: Norbert Sprenger, Jean-Richard Neeser
  • Patent number: 9854826
    Abstract: The invention discloses an oligosaccharide mixture comprising at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide. Food product, especially infant formula, comprising said oligosaccharide mixture.
    Type: Grant
    Filed: November 21, 2011
    Date of Patent: January 2, 2018
    Assignee: Nestec S.A.
    Inventors: Norbert Sprenger, Jean-Richard Neeser
  • Publication number: 20170310748
    Abstract: The disclosure describes components, apparatus and methods for providing network security between computing devices and/or networks on mobile platforms such as aircraft. One such apparatus may comprise: a first memory configured for data communication with a first computing device of the mobile platform; a second memory configured for data communication with a second computing device of the mobile platform; and a controller. The controller may be configured to detect a change in data stored In the first memory and cause the change in data stored in the first memory to be reflected in the second memory by causing data transfer from the first memory to the second memory. Data transfer between the first memory and the second memory may be conducted using a non-internet protocol.
    Type: Application
    Filed: December 4, 2014
    Publication date: October 26, 2017
    Inventors: Jean-Richard COTE, Jayson AGAGNIER
  • Publication number: 20170137430
    Abstract: The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity.
    Type: Application
    Filed: July 22, 2016
    Publication date: May 18, 2017
    Inventors: Vincent P. Sandanayaka, Sharon Shacham, Michael Kauffman, Sharon Shechter, Dilara McCauley, Yosef Landesman, William Senapedis, Jean-Richard Sanit-Martin
  • Patent number: 9428490
    Abstract: The invention generally relates to nuclear transport modulators, e.g CRM1 inhibitors, and more particularly to a compound represented by formula (I): or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula (I), or a pharmaceutically acceptable salt or composition thereof, e.g, in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity.
    Type: Grant
    Filed: July 26, 2012
    Date of Patent: August 30, 2016
    Assignee: Karyopharm Therapeutics Inc.
    Inventors: Vincent P. Sandanayaka, Sharon Shacham, Michael Kauffman, Sharon Shechter, Dilara McCauley, Yosef Landesman, William Senapedis, Jean-Richard Saint-Martin
  • Publication number: 20150335052
    Abstract: The invention discloses an oligosaccharide mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide, 5-90 wt % of at least one neutral oligosaccharide, 2-50 wt % of at least one sialylated oligosaccharide, and/or 5-70 wt % of at least one fucosylated oligosaccharide. The invention also discloses a food product, especially an infant formula, comprising said oligosaccharide mixture.
    Type: Application
    Filed: August 6, 2015
    Publication date: November 26, 2015
    Inventors: Norbert Sprenger, Jean-Richard Neeser
  • Patent number: 9161563
    Abstract: The invention discloses an oligosaccharide mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide, 5-90 wt % of at least one neutral oligosaccharide, 2-50 wt % of at least one sialylated oligosaccharide, and/or 5-70 wt % of at least one fucosylated oligosaccharide. The invention also discloses a food product, especially an infant formula, comprising said oligosaccharide mixture.
    Type: Grant
    Filed: November 21, 2011
    Date of Patent: October 20, 2015
    Assignee: Nestec S.A.
    Inventors: Norbert Sprenger, Jean-Richard Neeser
  • Publication number: 20150018332
    Abstract: The invention generally relates to nuclear transport modulators, e.g CRM1 inhibitors, and more particularly to a compound represented by formula (I): or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula (I), or a pharmaceutically acceptable salt or composition thereof, e.g, in the treatment, modulation and/or prevention of physiological conditions associated with CRM1 activity.
    Type: Application
    Filed: July 26, 2012
    Publication date: January 15, 2015
    Applicant: KARYOPHARM THERAPEUTICS INC.
    Inventors: Vincent P. Sandanayaka, Sharon Shacham, Michael Kauffman, Sharon Shechter, Dilara McCauley, Yosef Landesman, William Senapedis, Jean-Richard Saint-Martin
  • Patent number: 8710003
    Abstract: A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of diabetes or syndrome X. The invention also relates to a method of treatment or prevention of diabetes or syndrome X utilizing such compositions, a method for assessing proglucagon gene expression and GLP-1 release by a cell line derived from an adenocarcinoma of human caecum.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: April 29, 2014
    Assignee: Nestec S.A.
    Inventors: Raylene Alison Reimer, Christian Darimont-Nicolau, Katherine Mace, Sandrine Gremlich, Jean-Richard Neeser
  • Publication number: 20130251844
    Abstract: The invention discloses an oligosaccharide mixture comprising at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide. Food product, especially infant formula, comprising said oligosaccharide mixture.
    Type: Application
    Filed: November 21, 2011
    Publication date: September 26, 2013
    Applicant: NESTEC S.A.
    Inventors: Norbert Sprenger, Jean-Richard Neeser
  • Publication number: 20130236423
    Abstract: The invention discloses an oligosaccharide mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide, 5-90 wt % of at least one neutral oligosaccharide, 2-50 wt % of at least one sialylated oligosaccharide, and/or 5-70 wt % of at least one fucosylated oligosaccharide. The invention also discloses a food product, especially an infant formula, comprising said oligosaccharide mixture.
    Type: Application
    Filed: November 21, 2011
    Publication date: September 12, 2013
    Applicant: NESTEC S.A.
    Inventors: Norbert Sprenger, Jean-Richard Neeser